Cellular Immunoengineering

Track Chair(s)

• 

  Elizabeth Wayne, PhD (she/her/hers)

  Assistant Professor
  Carnegie Mellon University, United States
• JW

  John Wilson, Ph.D.

  Associate Professor
  Vanderbilt University
  Nashville, Tennessee, United States
• KM

  Kathryn Miller-Jensen

  Associate Professor
  Yale University, United States

Moderator(s)

• 

  Michelle Teplensky, PhD (she/her/hers)

  Assistant Professor
  Boston University
  Boston, Massachusetts, United States
• 

  Santiago Correa, PhD

  Columbia University

Presentations:

• 4:00 PM – 4:30 PM PDT

  Macrophage engineering to initiate anti-tumor immunity
  

  Keynote Speaker: Dennis E. Discher, PhD (he/him/his) – University of Pennsylvania

  Co-Author: Lawrence J. Dooling, PhD (he/him/his) – University of Pennsylvania
• 4:30 PM – 4:45 PM PDT

  Anti-inflammatory backpack-carrying macrophages for porcine traumatic brain injury
  

  Presenting Author: Rick Liao, PhD (he/him/his) – Harvard University

  Co-Author: Neha Kapate – Harvard University

  Co-Author: Beth Costine-Bartell – Massachusetts General Hospital

  Last Author: Samir Mitragotri – Harvard University
• 4:45 PM – 5:00 PM PDT

  Reprogramming T cells in inhibitory tumor microenvironment with TGFβ redirectors for improved ultrasound controllable CAR-T therapy
  

  Presenting Author: Longwei Liu (he/him/his) – University of Southern California

  Co-Author: Linshan Zhu, PhD (he/him/his) – University of Southern California

  Co-Author: Zhuohang Wu – University of Southern California

  Co-Author: Tianze Guo (he/him/his) – University of Southern California

  Primary Investigator: Yingxiao Wang – University of Southern California
• 5:00 PM – 5:15 PM PDT

  Modulation of T Cell Phenotype Through Presentation of Multiple Co-Stimulatory Ligands on a Functional Hydrogel
  

  Presenting Author: Manav Jain, B.S. (he/him/his) – Johns Hopkins University

  Co-Author: Natalie K. Livingston, BS (she/her/hers) – Johns Hopkins University

  Primary Investigator: Jonathan Schneck – Johns Hopkins University
• 5:15 PM – 5:30 PM PDT

  Engineering virus-specific T cells in vivo for CAR T cell therapy
  

  Presenting Author: Fang-Yi Su, PhD (she/her/hers) – Georgia Institute of Technology

  Co-Author: Ching Shen Chan – Georgia Institute of Technology

  Co-Author: Madhav Dhodapkar – Winship Cancer Institute at Emory University

  Primary Investigator: Gabriel Kwong – Georgia Institute of Technology